-
1دورية أكاديمية
المؤلفون: Caldevilla Rodríguez, Yadira, Bacallao Méndez, Raymed Antonio, Gutiérrez García, Francisco, Mañalich Comas, Reynaldo, Dávalos Iglesias, José Manuel
المصدر: Revista Cubana de Investigaciones Biomédicas; Vol. 40, No. 4 (2021): Octubre-Diciembre ; 1561-3011 ; 0864-0300
مصطلحات موضوعية: litiasis renal, enfermedad renal poliquística autosómica dominante, trastorno metabólico urinario, hipercalciuria
وصف الملف: application/pdf
العلاقة: https://revibiomedica.sld.cu/index.php/ibi/article/view/997/1067Test; Liu Y, Chen Y, Liao B, Luo D, Wang K, Li H, et al. Epidemiology of urolithiasis in Asia[J]. Asian Journal of Urology, 2018, 5(4): 205-214.; Sorokin I, Pearle MS. Medical therapy for nephrolithiasis: State of the art. Asian J Urol. 2018; 5(4):243-255.; Sorensen MD. Activity, Energy Intake, Obesity, and the Risk of Incident Kidney Stones in Postmenopausal Women: A Report from the Women’s Health Initiative. J Am Soc Nephrol 2014; 25(2): 362–9.; McMahon EJ, Campbell KL, Bauer JD, Mudge DW. Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev. 2015; 18(2):CD010070. doi:10.1002/14651858.CD010070.pub2.; Mallet A, Tunnicliffe D. Management of Renal Stone Disease. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline. Introduction to the KHA- CARI Guidelines on ADPKD. Semin Nephrol 2015; 35:521-3.; Pak CY, Poindexter JR, Adams-Huet B, Pearle MS. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003; 115:26.; Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 2015; 67(4):750-63.; Sommerer C, Zeier M. Clinical manifestation and management of ADPKD in Western Countries. Kidney Dis (Basel). 2016 ;2(3):120-127.; Tiselius HG, Daudon M, Thomas K, Seitz C. Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm. Eur Urol Focus. 2017; 3(1):62-71.; Dubois D, Dubois E. F. A formula to estimate the approximate surface area if height and weight be known. Arch. Intern.Med. 1916,17:862.; Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014 May; 63(5):713-35.; Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol 2000; 13 (3): S45-S50.; Bacallao Méndez RA, Victores Aguiar I, Mañalich Comas R, Gutiérrez García F, Llerena Ferrer B, Almaguer López IM. Caracterización clínico epidemiológica de la litiasis urinaria en un área rural de Artemisa. Revista Cubana de Investigaciones Biomédicas. 2016; 35(4): 300-10.; Finlayson B. Symposium on renal lithiasis in review. UrolClin North Am 1974; 1:181-212.; Bae SR, Seong JM, Kim LY, Paick SH, Kim HG, Lho YS, et al. The epidemiology of reno-ureteral stone disease in Koreans: a nationwide population-based study. Urolithiasis. Apr 2014; 42(2):109-14.; Bacallao Méndez RA, Madrid Mancia C, Mañalich Comas R, Gutiérrez García F, Badell Moore A. Trastornos metabólicos renales en pacientes cubanos adultos con litiasis urinarias. Rev Cubana Med 2014; 53(4):456-67.; Idrizi A, Barbullushi M, Gjata M, Roshi E, Backa T, Kodra S. Prevalence of nephrolithiasis in polycystic kidney disease. Central European Journal of Medicine 2011; 6 (4):497-51.; Pak, CY, Poindexter, JR, Adams-Huet, B, Pearle, MS. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003; 115:26.; Torres VE, Erickson SB, Smith LH. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1988; 11(4):318-25.; Grampsas SA, Chandhoke PS, Fan J, Glass MA, Townsend R, Jonhson AM, Gabow P. Anatomic and metabolic risks factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000; 36(1):53-7.; Torres VE, Wilson DM, Hattery RR, Segura JW. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1993; 22(4):513-9.; Kathleen A. Barry MD. Citrate Salts for Preventing and Treating Calcium-Containing Kidney Stones in Adults. Am Fam Physician. 2017; 95(9):552-3.; Coe FL, Favus MJ, Asplin JR : Nefrolitiasis. En Brenner B. The Kidney. Philadelphia: Saunders, 2005, Pp. 1820-66.; Pak CYC. Medical prevention of renal stone disease. Nephron 1999; 81 (1):60-5.; Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. N Engl J Med. 1979; 300(7):337-40.; Nishiura JL, Neves R, Heilberg IP. Evaluation of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease Patients. Clin J Am Soc Nephrol. 2009; 4(4): 838-44.; Lorenzo-Sellares V, Torres-Ramírez A. Primary hyperoxaluria. Nefrología 2014; 34(3): 273-424.; Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis an update of a 1980 protocol. Am J Med 1995; 98:50-9.; Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: New insights after 14 years of follow up. J Am SocNephrol 2004; 15:3225.; Curhan GC, Willet WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses’ Health StudyII. Arch Intern Med 2004; 164:885.; Xu C, Zhang C, Wang XL, et al. Self-Fluid Management in Prevention of Kidney Stones: A PRISMA-Compliant Systematic Review and Dose-Response Meta-Analysis of Observational Studies. Medicine (Baltimore). 2015;94(27):e1042. doi:10.1097/MD.0000000000001042.; Cheungpasitporn W, Rossetti S, Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis.J Nephrol. 2016; 29(2):211-9.; Bacallao Méndez R, Caldevilla Rodríguez Y, Mañalich Comas R, Gutiérrez García F, Badell Moore A, Llerena Ferrer B. Efecto de la ingestión de sal en la excreción renal de agua en pacientes urolitiásicos. Revista Cubana de Investigaciones Biomédicas. 2016; 35(4):323-30.; Vikrant S, Parashar A. Autosomal dominant polycystic kidney disease: Study of clinical characteristics in an Indian population. Saudi Journal of Kidney Diseases and Transplantation 2017; 28: 115-124.; https://revibiomedica.sld.cu/index.php/ibi/article/view/997Test
-
2دورية أكاديمية
المؤلفون: López-Marín, Laura, Orantes-Navarro, Carlos Manuel, Herrera-Valdés, Raúl Ambrosio, Almaguer-López, Miguel Marcial, Bacallao Méndez, Raymed Antonio, Vela-Parada, Xavier Fernando, Henriquez Ticas, David Omar, Gavarrete-Escobar, Esmeralda, Vazquez Martul, Eduardo
المساهمون: Instituto Nacional de Salud de El Salvador, Instituto de Nefrología de Cuba, Complejo Hospital Universitario A Coruña
المصدر: Revista Cubana de Investigaciones Biomédicas; Vol. 40, No. 3 (2021): Julio-Septiembre ; 1561-3011 ; 0864-0300
مصطلحات موضوعية: electron microscopy, chronic kidney disease, chronic interstitial nephritis, microscopía electrónica, enfermedad renal crónica, nefritis intersticial crónica
وصف الملف: application/pdf
العلاقة: https://revibiomedica.sld.cu/index.php/ibi/article/view/1071/1041Test; https://revibiomedica.sld.cu/index.php/ibi/article/downloadSuppFile/1071/504Test; Carrero JJ, Hecking M, Ulasi I, Sola L, Thomas B. Chronic Kidney Disease, Gender, and Access to Care: A Global Perspective. Semin Nephrol. 2017;37(3):296-308.; Perico N, Remuzzi G. Prevention programs for chronic kidney disease in low-income countries. Intern Emerg Med. 2016;11(3):385-9.; Peraza S, Wesseling C, Aragón A, Leiva R, García RA, Torres C, et al. Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis. 2012;59(4):531-40.; Orantes CM, Herrera R, Almaguer M, Brizuela EG, Hernández C, Bayarre H, et al. Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa Study, 2009. MEDICC Rev. 2011;13(4):14-22.; Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, et al. What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol. 2012;13:10-8.; Nanayakkara S, Komiya T, Ratuatunga N, Senevirathna ST, Harada KH, Hitomi T, et al. Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in North Central Province of Sri Lanka. Environ Health Prev Med. 2012;17(3):213-21.; Orantes CM, Herrera R, Almaguer M, Brizuela EG, Núñez L, Alvarado NP, et al. Epidemiological characterization of chronic kidney disease in agricultural communities in El Salvador. MEDICC Rev. 2014;15(2):23-30.; García-Trabanino R, Trujillo Z, Colorado AV. Prevalencia de pacientes con tratamiento sustitutivo renal en El Salvador en 2014. Nefrología. 2016;36(6):631-6.; Herrera-Valdés R, Orantes CM, Almaguer-López M, López Marín L, Alfonso Arévalo P, Smith-González MJ. Clinical Characteristics of Chronic Kidney Disease of Non-Traditional Causes in Women of Agricultural Communities in El Salvador. Clin Nephrol. 2015;83(7 Suppl 1):56-63.; Herrera R, Orantes CM, Almaguer M, Alfonso P, Bayarre HD, Leiva IM, et al. Clinical Characteristics of Chronic Kidney Disease of Nontraditional Causes in Salvadoran Farming Communities. MEDICC Rev. 2014;15(2):39-48.; López-Marín L, Chávez Y, García XA, Flores WM, García YM, Herrera R, et al. Histopathology of chronic kidney disease of unknown etiology in Salvador an agricultural communities. MEDICC Rev. 2014;16(2):49-54.; Wijkström J, Leiva R, Elinder CG, Leiva S, Trujillo Z, Trujillo L, et al. Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America. Am J Kidney Dis. 2013;62:908-18.; Wijkström J, González-Quiroz M, Hernandez M, Trujillo Z, Hultenby K, Ring A, et al. Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy. Am J Kidney Dis. 2017;69:626-36.; Fischer RSB, Vangala C, Truong L, Mandayam S, Chavarria D, Granera-Llanes OM. Early detection of acute tubulointerstitial nephritis in the genesis of Mesoamerican nephropathy. Kidney Int. 2018;93:681-90.; National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.; MacGregor MS, Boag DE, Innes A. Chronic kidney disease: evolving strategies for detection and management of impaired renal function. QJM. 2006;99(6):365-75.; Quinteros E, Ribó A, Mejía R, López A, Belteton W, Comandari A, et al. Heavy metals and pesticide exposure from agricultural activities and former agrochemical factory in a Salvadoran rural community. Environ Sci Pollut Res Int. 2017;24(2):1662-76.; Herrera Valdés R, Almaguer López M, Orantes Navarro CM, López Marín L, Brizuela Díaz EG, Bayarre Vea H, et al. Chronic Interstitial Nephritis of Nontraditional Causes in Salvadoran Agricultural Communities. Clin Nephrol. 2020;93(1):60-7.; Delles C, Vanholder R. Chronic kidney disease. Clin Sci (Lond). 2017;131(3):225-6.; Bacallao-Méndez R. Transporte tubular y uso de diuréticos. En: Bacallao-Méndez R, Mañalich-Comas R, Galvizu-Díaz K, editores. Fisiología y exploración funcional renal. 1.ª ed. La Habana: Editorial Ciencias Médicas; 2016. p. 44-91.; Sheerin NS, Sacks SH, Fogazzi GB. In vitro erythrophagocytosis by renal tubular cells and tubular toxicity by haemoglobin and iron. Nephrol Dial Transplant. 1999;14(6):1391-7.; Parenti G, Andria G, Ballabio A. Lysosomal storage diseases: from pathophysiology to therapy. Annu Rev Med. 2015;66:471-86.; Ballabio A. The awesome lysosome. EMBO Mol Med. 2016;8(2):73-6.; Boustany RN, Kaye E, Alroy J. Ultrastructural findings in skin from patients with Niemann-Pick disease, type C. Pediatr Neurol. 1990;6:177.; López-Marín L, Bacallao R, González L, Rodríguez CA, de la Concepción OM, Matos M. Hiperaldosteronismo primario por adenoma suprarrenal con cuerpos de espironolactona. Presentación de un caso. Rev Cub Urol. 2013;2(1):122-30.; Nogawa K, Kobayashi E, Okubo Y, Suwazono Y. Environmental cadmium exposure, adverse effects and preventive measures in Japan. Biometals. 2004;17:581-8.; Hellström L, Elinder CG, Dahlberg B, Lundberg M, Järup L, Persson B, et al. Cadmium exposure and end-stage renal disease. Am J Kidney Dis. 2001;38(5):1001-8.; https://revibiomedica.sld.cu/index.php/ibi/article/view/1071Test
-
3دورية أكاديمية
المؤلفون: Caldevilla Rodríguez, Yadira, Bacallao Méndez, Raymed Antonio, Gutiérrez García, Francisco, Mañalich Comas, Reynaldo, Dávalos Iglesias, José Manuel
المصدر: Revista Cubana de Investigaciones Biomédicas; Vol. 40, No. 4 (2021): Octubre-Diciembre ; 1561-3011 ; 0864-0300
مصطلحات موضوعية: litiasis renal, enfermedad renal poliquística autosómica dominante, trastorno metabólico urinario, hipercalciuria
وصف الملف: application/pdf
العلاقة: http://www.revibiomedica.sld.cu/index.php/ibi/article/view/997/1067Test; Liu Y, Chen Y, Liao B, Luo D, Wang K, Li H, et al. Epidemiology of urolithiasis in Asia[J]. Asian Journal of Urology, 2018, 5(4): 205-214.; Sorokin I, Pearle MS. Medical therapy for nephrolithiasis: State of the art. Asian J Urol. 2018; 5(4):243-255.; Sorensen MD. Activity, Energy Intake, Obesity, and the Risk of Incident Kidney Stones in Postmenopausal Women: A Report from the Women’s Health Initiative. J Am Soc Nephrol 2014; 25(2): 362–9.; McMahon EJ, Campbell KL, Bauer JD, Mudge DW. Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev. 2015; 18(2):CD010070. doi:10.1002/14651858.CD010070.pub2.; Mallet A, Tunnicliffe D. Management of Renal Stone Disease. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline. Introduction to the KHA- CARI Guidelines on ADPKD. Semin Nephrol 2015; 35:521-3.; Pak CY, Poindexter JR, Adams-Huet B, Pearle MS. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003; 115:26.; Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 2015; 67(4):750-63.; Sommerer C, Zeier M. Clinical manifestation and management of ADPKD in Western Countries. Kidney Dis (Basel). 2016 ;2(3):120-127.; Tiselius HG, Daudon M, Thomas K, Seitz C. Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm. Eur Urol Focus. 2017; 3(1):62-71.; Dubois D, Dubois E. F. A formula to estimate the approximate surface area if height and weight be known. Arch. Intern.Med. 1916,17:862.; Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014 May; 63(5):713-35.; Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol 2000; 13 (3): S45-S50.; Bacallao Méndez RA, Victores Aguiar I, Mañalich Comas R, Gutiérrez García F, Llerena Ferrer B, Almaguer López IM. Caracterización clínico epidemiológica de la litiasis urinaria en un área rural de Artemisa. Revista Cubana de Investigaciones Biomédicas. 2016; 35(4): 300-10.; Finlayson B. Symposium on renal lithiasis in review. UrolClin North Am 1974; 1:181-212.; Bae SR, Seong JM, Kim LY, Paick SH, Kim HG, Lho YS, et al. The epidemiology of reno-ureteral stone disease in Koreans: a nationwide population-based study. Urolithiasis. Apr 2014; 42(2):109-14.; Bacallao Méndez RA, Madrid Mancia C, Mañalich Comas R, Gutiérrez García F, Badell Moore A. Trastornos metabólicos renales en pacientes cubanos adultos con litiasis urinarias. Rev Cubana Med 2014; 53(4):456-67.; Idrizi A, Barbullushi M, Gjata M, Roshi E, Backa T, Kodra S. Prevalence of nephrolithiasis in polycystic kidney disease. Central European Journal of Medicine 2011; 6 (4):497-51.; Pak, CY, Poindexter, JR, Adams-Huet, B, Pearle, MS. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003; 115:26.; Torres VE, Erickson SB, Smith LH. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1988; 11(4):318-25.; Grampsas SA, Chandhoke PS, Fan J, Glass MA, Townsend R, Jonhson AM, Gabow P. Anatomic and metabolic risks factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000; 36(1):53-7.; Torres VE, Wilson DM, Hattery RR, Segura JW. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1993; 22(4):513-9.; Kathleen A. Barry MD. Citrate Salts for Preventing and Treating Calcium-Containing Kidney Stones in Adults. Am Fam Physician. 2017; 95(9):552-3.; Coe FL, Favus MJ, Asplin JR : Nefrolitiasis. En Brenner B. The Kidney. Philadelphia: Saunders, 2005, Pp. 1820-66.; Pak CYC. Medical prevention of renal stone disease. Nephron 1999; 81 (1):60-5.; Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. N Engl J Med. 1979; 300(7):337-40.; Nishiura JL, Neves R, Heilberg IP. Evaluation of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease Patients. Clin J Am Soc Nephrol. 2009; 4(4): 838-44.; Lorenzo-Sellares V, Torres-Ramírez A. Primary hyperoxaluria. Nefrología 2014; 34(3): 273-424.; Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis an update of a 1980 protocol. Am J Med 1995; 98:50-9.; Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: New insights after 14 years of follow up. J Am SocNephrol 2004; 15:3225.; Curhan GC, Willet WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses’ Health StudyII. Arch Intern Med 2004; 164:885.; Xu C, Zhang C, Wang XL, et al. Self-Fluid Management in Prevention of Kidney Stones: A PRISMA-Compliant Systematic Review and Dose-Response Meta-Analysis of Observational Studies. Medicine (Baltimore). 2015;94(27):e1042. doi:10.1097/MD.0000000000001042.; Cheungpasitporn W, Rossetti S, Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis.J Nephrol. 2016; 29(2):211-9.; Bacallao Méndez R, Caldevilla Rodríguez Y, Mañalich Comas R, Gutiérrez García F, Badell Moore A, Llerena Ferrer B. Efecto de la ingestión de sal en la excreción renal de agua en pacientes urolitiásicos. Revista Cubana de Investigaciones Biomédicas. 2016; 35(4):323-30.; Vikrant S, Parashar A. Autosomal dominant polycystic kidney disease: Study of clinical characteristics in an Indian population. Saudi Journal of Kidney Diseases and Transplantation 2017; 28: 115-124.; http://www.revibiomedica.sld.cu/index.php/ibi/article/view/997Test
-
4دورية أكاديمية
المؤلفون: López-Marín, Laura, Orantes-Navarro, Carlos Manuel, Herrera-Valdés, Raúl Ambrosio, Almaguer-López, Miguel Marcial, Bacallao Méndez, Raymed Antonio, Vela-Parada, Xavier Fernando, Henriquez Ticas, David Omar, Gavarrete-Escobar, Esmeralda, Vazquez Martul, Eduardo
المساهمون: Instituto Nacional de Salud de El Salvador, Instituto de Nefrología de Cuba, Complejo Hospital Universitario A Coruña
المصدر: Revista Cubana de Investigaciones Biomédicas; Vol. 40, No. 3 (2021): Julio-Septiembre ; 1561-3011 ; 0864-0300
مصطلحات موضوعية: electron microscopy, chronic kidney disease, chronic interstitial nephritis, microscopía electrónica, enfermedad renal crónica, nefritis intersticial crónica
وصف الملف: application/pdf
العلاقة: http://www.revibiomedica.sld.cu/index.php/ibi/article/view/1071/1041Test; http://www.revibiomedica.sld.cu/index.php/ibi/article/downloadSuppFile/1071/504Test; Carrero JJ, Hecking M, Ulasi I, Sola L, Thomas B. Chronic Kidney Disease, Gender, and Access to Care: A Global Perspective. Semin Nephrol. 2017;37(3):296-308.; Perico N, Remuzzi G. Prevention programs for chronic kidney disease in low-income countries. Intern Emerg Med. 2016;11(3):385-9.; Peraza S, Wesseling C, Aragón A, Leiva R, García RA, Torres C, et al. Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis. 2012;59(4):531-40.; Orantes CM, Herrera R, Almaguer M, Brizuela EG, Hernández C, Bayarre H, et al. Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa Study, 2009. MEDICC Rev. 2011;13(4):14-22.; Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, et al. What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol. 2012;13:10-8.; Nanayakkara S, Komiya T, Ratuatunga N, Senevirathna ST, Harada KH, Hitomi T, et al. Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in North Central Province of Sri Lanka. Environ Health Prev Med. 2012;17(3):213-21.; Orantes CM, Herrera R, Almaguer M, Brizuela EG, Núñez L, Alvarado NP, et al. Epidemiological characterization of chronic kidney disease in agricultural communities in El Salvador. MEDICC Rev. 2014;15(2):23-30.; García-Trabanino R, Trujillo Z, Colorado AV. Prevalencia de pacientes con tratamiento sustitutivo renal en El Salvador en 2014. Nefrología. 2016;36(6):631-6.; Herrera-Valdés R, Orantes CM, Almaguer-López M, López Marín L, Alfonso Arévalo P, Smith-González MJ. Clinical Characteristics of Chronic Kidney Disease of Non-Traditional Causes in Women of Agricultural Communities in El Salvador. Clin Nephrol. 2015;83(7 Suppl 1):56-63.; Herrera R, Orantes CM, Almaguer M, Alfonso P, Bayarre HD, Leiva IM, et al. Clinical Characteristics of Chronic Kidney Disease of Nontraditional Causes in Salvadoran Farming Communities. MEDICC Rev. 2014;15(2):39-48.; López-Marín L, Chávez Y, García XA, Flores WM, García YM, Herrera R, et al. Histopathology of chronic kidney disease of unknown etiology in Salvador an agricultural communities. MEDICC Rev. 2014;16(2):49-54.; Wijkström J, Leiva R, Elinder CG, Leiva S, Trujillo Z, Trujillo L, et al. Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America. Am J Kidney Dis. 2013;62:908-18.; Wijkström J, González-Quiroz M, Hernandez M, Trujillo Z, Hultenby K, Ring A, et al. Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy. Am J Kidney Dis. 2017;69:626-36.; Fischer RSB, Vangala C, Truong L, Mandayam S, Chavarria D, Granera-Llanes OM. Early detection of acute tubulointerstitial nephritis in the genesis of Mesoamerican nephropathy. Kidney Int. 2018;93:681-90.; National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.; MacGregor MS, Boag DE, Innes A. Chronic kidney disease: evolving strategies for detection and management of impaired renal function. QJM. 2006;99(6):365-75.; Quinteros E, Ribó A, Mejía R, López A, Belteton W, Comandari A, et al. Heavy metals and pesticide exposure from agricultural activities and former agrochemical factory in a Salvadoran rural community. Environ Sci Pollut Res Int. 2017;24(2):1662-76.; Herrera Valdés R, Almaguer López M, Orantes Navarro CM, López Marín L, Brizuela Díaz EG, Bayarre Vea H, et al. Chronic Interstitial Nephritis of Nontraditional Causes in Salvadoran Agricultural Communities. Clin Nephrol. 2020;93(1):60-7.; Delles C, Vanholder R. Chronic kidney disease. Clin Sci (Lond). 2017;131(3):225-6.; Bacallao-Méndez R. Transporte tubular y uso de diuréticos. En: Bacallao-Méndez R, Mañalich-Comas R, Galvizu-Díaz K, editores. Fisiología y exploración funcional renal. 1.ª ed. La Habana: Editorial Ciencias Médicas; 2016. p. 44-91.; Sheerin NS, Sacks SH, Fogazzi GB. In vitro erythrophagocytosis by renal tubular cells and tubular toxicity by haemoglobin and iron. Nephrol Dial Transplant. 1999;14(6):1391-7.; Parenti G, Andria G, Ballabio A. Lysosomal storage diseases: from pathophysiology to therapy. Annu Rev Med. 2015;66:471-86.; Ballabio A. The awesome lysosome. EMBO Mol Med. 2016;8(2):73-6.; Boustany RN, Kaye E, Alroy J. Ultrastructural findings in skin from patients with Niemann-Pick disease, type C. Pediatr Neurol. 1990;6:177.; López-Marín L, Bacallao R, González L, Rodríguez CA, de la Concepción OM, Matos M. Hiperaldosteronismo primario por adenoma suprarrenal con cuerpos de espironolactona. Presentación de un caso. Rev Cub Urol. 2013;2(1):122-30.; Nogawa K, Kobayashi E, Okubo Y, Suwazono Y. Environmental cadmium exposure, adverse effects and preventive measures in Japan. Biometals. 2004;17:581-8.; Hellström L, Elinder CG, Dahlberg B, Lundberg M, Järup L, Persson B, et al. Cadmium exposure and end-stage renal disease. Am J Kidney Dis. 2001;38(5):1001-8.; http://www.revibiomedica.sld.cu/index.php/ibi/article/view/1071Test
-
5دورية أكاديمية
المصدر: Revista Cubana de Investigaciones Biomédicas; Vol. 37, No. 3 (2018): Julio-Septiembre ; 1561-3011 ; 0864-0300
مصطلحات موضوعية: nefritis intersticial, erupciones por medicamentos, fenitoína, eosinofilia, pruebas de función renal, hemodiálisis, lesión renal aguda
وصف الملف: text/html
-
6دورية أكاديمية
المؤلفون: Bacallao Méndez, Raymed Antonio, Cabrera Eugenio, Adriana Pamela, Mañalich Comas, Reynaldo, Gutiérrez García, Francisco
المصدر: Revista Cubana de Investigaciones Biomédicas; Vol. 37, No. 3 (2018): Julio-Septiembre ; 1561-3011 ; 0864-0300
مصطلحات موضوعية: tasa de filtración glomerular, urolitiasis, creatinina, insuficiencia renal, índice de masa corporal, obesidad
وصف الملف: text/html
-
7دورية أكاديمية
المصدر: Revista Cubana de Investigaciones Biomédicas; Vol. 37, No. 3 (2018): Julio-Septiembre ; 1561-3011 ; 0864-0300
مصطلحات موضوعية: nefritis intersticial, erupciones por medicamentos, fenitoína, eosinofilia, pruebas de función renal, hemodiálisis, lesión renal aguda
وصف الملف: text/html
-
8دورية أكاديمية
المؤلفون: Bacallao Méndez, Raymed Antonio, Cabrera Eugenio, Adriana Pamela, Mañalich Comas, Reynaldo, Gutiérrez García, Francisco
المصدر: Revista Cubana de Investigaciones Biomédicas; Vol. 37, No. 3 (2018): Julio-Septiembre ; 1561-3011 ; 0864-0300
مصطلحات موضوعية: tasa de filtración glomerular, urolitiasis, creatinina, insuficiencia renal, índice de masa corporal, obesidad
وصف الملف: text/html
